ZLDPF / Zealand Pharma A/S - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Zealand Pharma A/S
US ˙ OTCPK ˙ DK0060257814

Mga Batayang Estadistika
LEI 549300ITBB1ULBL4CZ12
CIK 1573728
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Zealand Pharma A/S
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
July 26, 2017 EX-1

=============================================================== ZEALAND PHARMA A/S THE BANK OF NEW YORK MELLON As Depositary OWNERS AND HOLDERS OF AMERICAN DEPOSITARY SHARES Deposit Agreement ____________________________, 2017 TABLE OF CONTENTS

=============================================================== ZEALAND PHARMA A/S AND THE BANK OF NEW YORK MELLON As Depositary AND OWNERS AND HOLDERS OF AMERICAN DEPOSITARY SHARES Deposit Agreement , 2017 =============================================================== TABLE OF CONTENTS ARTICLE 1.

July 26, 2017 F-6

As filed with the Securities and Exchange Commission on July 26, 2017

F-6 1 zeaa326499f6.htm FORM F-6 As filed with the Securities and Exchange Commission on July 26, 2017 Registration No. 333- SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-6 REGISTRATION STATEMENT under THE SECURITIES ACT OF 1933 For Depositary Shares ZEALAND PHARMA A/S (Exact name of issuer of deposited securities as specified in its charter) N/A (Translation of issuer's name int

July 26, 2017 EX-4

Emmet, Marvin & Martin, LLP Counsellors at Law 120 Broadway New York, New York 10271 (212) 238-3000 (212) 653-1760 Fax: (212) 238-3100 Fax: (212) 653-1730

Writer?s Direct Dial EXHIBIT 4 Emmet, Marvin & Martin, LLP Counsellors at Law 120 Broadway New York, New York 10271 (212) 238-3000 (212) 653-1760 Fax: (212) 238-3100 Fax: (212) 653-1730 http://www.

April 4, 2013 EX-4

Emmet, Marvin & Martin, LLP Counsellors at Law 120 Broadway New York, New York 10271 (212) 238-3000 (212) 653-1760 Fax: (212) 238-3100 Fax: (212) 653-1730

Writer’s Direct Dial EXHIBIT 4 Emmet, Marvin & Martin, LLP Counsellors at Law 120 Broadway New York, New York 10271 (212) 238-3000 (212) 653-1760 Fax: (212) 238-3100 Fax: (212) 653-1730 http://www.

April 4, 2013 EX-1

THE BANK OF NEW YORK MELLON AMERICAN DEPOSITARY RECEIPT FOR ORDINARY SHARES OF ZEALAND PHARMA A/S (INCORPORATED UNDER THE LAWS OF DENMARK)

AMERICAN DEPOSITARY SHARES (One (1) American Depositary Share represents One (1) Share) THE BANK OF NEW YORK MELLON AMERICAN DEPOSITARY RECEIPT FOR ORDINARY SHARES OF ZEALAND PHARMA A/S (INCORPORATED UNDER THE LAWS OF DENMARK) The Bank of New York Mellon, as depositary (hereinafter called the “Depositary”), hereby certifies (i) that there have been deposited with the Depositary or its agent, nomin

April 4, 2013 F-6EF

- FORM F-6

F-6EF 1 zealf6.htm FORM F-6 As filed with the Securities and Exchange Commission on April 4, 2013 Registration No. 333- SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-6 REGISTRATION STATEMENT under THE SECURITIES ACT OF 1933 For Depositary Shares Evidenced by American Depositary Receipts of ZEALAND PHARMA A/S (Exact name of issuer of deposited securities as specified in its chart

Other Listings
DK:ZEAL DKK 449.40
GB:0NZU
GB:ZEALC
DE:22Z € 61.00
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista